NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $707,927 | +0.9% | 6,950 | 0.0% | 0.02% | 0.0% |
| Q2 2023 | $701,325 | +90.1% | 6,950 | +64.4% | 0.02% | -66.7% |
| Q2 2020 | $369,000 | +7.3% | 4,228 | +1.2% | 0.04% | -8.2% |
| Q1 2020 | $344,000 | -13.6% | 4,176 | -0.7% | 0.05% | +25.6% |
| Q4 2019 | $398,000 | +9.0% | 4,205 | 0.0% | 0.04% | 0.0% |
| Q3 2019 | $365,000 | -4.9% | 4,205 | 0.0% | 0.04% | -4.9% |
| Q2 2019 | $384,000 | -5.0% | 4,205 | 0.0% | 0.04% | -10.9% |
| Q1 2019 | $404,000 | +11.9% | 4,205 | 0.0% | 0.05% | -2.1% |
| Q4 2018 | $361,000 | -0.3% | 4,205 | 0.0% | 0.05% | +14.6% |
| Q3 2018 | $362,000 | +13.8% | 4,205 | 0.0% | 0.04% | +17.1% |
| Q2 2018 | $318,000 | -8.6% | 4,205 | -2.3% | 0.04% | -22.2% |
| Q1 2018 | $348,000 | -16.7% | 4,305 | -13.6% | 0.04% | -4.3% |
| Q4 2017 | $418,000 | -28.3% | 4,983 | -26.6% | 0.05% | -28.8% |
| Q3 2017 | $583,000 | – | 6,791 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
| Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
| MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
| Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
| SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
| GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
| Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
| First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
| PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |